MGTX
Price
$7.30
Change
-$0.19 (-2.54%)
Updated
Aug 29 closing price
Capitalization
587.27M
65 days until earnings call
TLRY
Price
$1.38
Change
-$0.09 (-6.12%)
Updated
Aug 29 closing price
Capitalization
1.52B
30 days until earnings call
Interact to see
Advertisement

MGTX vs TLRY

Header iconMGTX vs TLRY Comparison
Open Charts MGTX vs TLRYBanner chart's image
MeiraGTx Holdings
Price$7.30
Change-$0.19 (-2.54%)
Volume$242.02K
Capitalization587.27M
Tilray Brands
Price$1.38
Change-$0.09 (-6.12%)
Volume$51.26M
Capitalization1.52B
MGTX vs TLRY Comparison Chart in %
Loading...
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Regeneron Pharmaceuticals (NASDAQ:REGN), IQVIA Holdings (NYSE:IQV), Biogen (NASDAQ:BIIB), Incyte Corp (NASDAQ:INCY), Illumina (NASDAQ:ILMN), Exelixis (NASDAQ:EXEL), Moderna (NASDAQ:MRNA), Exact Sciences Corp (NASDAQ:EXAS).

Industry description

Few industries pique investor interest like the high-risk, high-reward biotechnology sector. It is not unusual for a biotech company’s stock to soar in value following the development of a successful product...even if it is just as likely that tens of millions of dollars in research will lead to nothing substantial. Biotech companies earn headlines for developing lifesaving and (potentially) massively lucrative treatments for illness, but the industry’s scope extends beyond healthcare to food and agriculture, industrial processing, and more. Any company producing technology that incorporates biological organisms falls within the sector. The search for the next big thing in biotech may come with risk, but investors have reason for optimism. Biotech products like DNA sequencing and gene therapy are experiencing increased demand and decreasing prices, while rising populations around the world mean demand for food and agricultural products resistant to environmental factors. Biotech’s biggest names include multinational corporations like Johnson & Johnson, Amgen, and Roche, who each sport market capitalizations in the hundreds of billions of dollars. With new government rules opening China as a market for new treatments, the biotech sector holds significant growth potential – and corresponding profitability for investors.

Market Cap

The average market capitalization across the biotechnology Theme is 6.85B. The market cap for tickers in the group ranges from 658 to 186.06B. TMO holds the highest valuation in this group at 186.06B. The lowest valued company is MTEM at 658.

High and low price notable news

The average weekly price growth across all stocks in the biotechnology Theme was -1%. For the same Theme, the average monthly price growth was 11%, and the average quarterly price growth was 37%. NBY experienced the highest price growth at 96%, while OTLK experienced the biggest fall at -68%.

Volume

The average weekly volume growth across all stocks in the biotechnology Theme was -7%. For the same stocks of the Theme, the average monthly volume growth was -38% and the average quarterly volume growth was -32%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 59
P/E Growth Rating: 76
Price Growth Rating: 54
SMR Rating: 87
Profit Risk Rating: 90
Seasonality Score: -26 (-100 ... +100)

Notable companies

The most notable companies in this group are Tilray Brands (NASDAQ:TLRY).

Market Cap

The average market capitalization across the group is 1.05B. The market cap for tickers in the group ranges from 587.27M to 1.52B. TLRY holds the highest valuation in this group at 1.52B. The lowest valued company is MGTX at 587.27M.

High and low price notable news

The average weekly price growth across all stocks in the group was 7%. For the same group, the average monthly price growth was 59%, and the average quarterly price growth was 45%. TLRY experienced the highest price growth at 20%, while MGTX experienced the biggest fall at -7%.

Volume

The average weekly volume growth across all stocks in the group was -11%. For the same stocks of the group, the average monthly volume growth was -19% and the average quarterly volume growth was -7%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 74
P/E Growth Rating: 97
Price Growth Rating: 38
SMR Rating: 99
Profit Risk Rating: 100
Seasonality Score: 0 (-100 ... +100)
VS
MGTX vs. TLRY commentary
Sep 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGTX is a Buy and TLRY is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 02, 2025
Stock price -- (MGTX: $7.30 vs. TLRY: $1.38)
Brand notoriety: MGTX: Not notable vs. TLRY: Notable
MGTX represents the Biotechnology, while TLRY is part of the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: MGTX: 47% vs. TLRY: 83%
Market capitalization -- MGTX: $587.27M vs. TLRY: $1.52B
MGTX [@Biotechnology] is valued at $587.27M. TLRY’s [@Pharmaceuticals: Generic] market capitalization is $1.52B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $69.31B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MGTX’s FA Score shows that 0 FA rating(s) are green whileTLRY’s FA Score has 0 green FA rating(s).

  • MGTX’s FA Score: 0 green, 5 red.
  • TLRY’s FA Score: 0 green, 5 red.
According to our system of comparison, TLRY is a better buy in the long-term than MGTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MGTX’s TA Score shows that 3 TA indicator(s) are bullish while TLRY’s TA Score has 4 bullish TA indicator(s).

  • MGTX’s TA Score: 3 bullish, 5 bearish.
  • TLRY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, TLRY is a better buy in the short-term than MGTX.

Price Growth

MGTX (@Biotechnology) experienced а -6.77% price change this week, while TLRY (@Pharmaceuticals: Generic) price change was +20.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.70%. For the same industry, the average monthly price growth was +20.57%, and the average quarterly price growth was +29.45%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.55%. For the same industry, the average monthly price growth was +67.47%, and the average quarterly price growth was +80.21%.

Reported Earning Dates

MGTX is expected to report earnings on Nov 06, 2025.

TLRY is expected to report earnings on Oct 02, 2025.

Industries' Descriptions

@Biotechnology (-0.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Pharmaceuticals: Generic (+1.55% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TLRY($1.52B) has a higher market cap than MGTX($587M). MGTX YTD gains are higher at: 19.869 vs. TLRY (3.759). MGTX has higher annual earnings (EBITDA): -132.21M vs. TLRY (-2.13B). TLRY has more cash in the bank: 256M vs. MGTX (32.2M). MGTX has less debt than TLRY: MGTX (80.5M) vs TLRY (329M). TLRY has higher revenues than MGTX: TLRY (821M) vs MGTX (37.9M).
MGTXTLRYMGTX / TLRY
Capitalization587M1.52B39%
EBITDA-132.21M-2.13B6%
Gain YTD19.8693.759529%
P/E RatioN/AN/A-
Revenue37.9M821M5%
Total Cash32.2M256M13%
Total Debt80.5M329M24%
FUNDAMENTALS RATINGS
MGTX vs TLRY: Fundamental Ratings
MGTX
TLRY
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
53
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
4334
P/E GROWTH RATING
1..100
10094
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TLRY's Valuation (53) in the Biotechnology industry is somewhat better than the same rating for MGTX (96). This means that TLRY’s stock grew somewhat faster than MGTX’s over the last 12 months.

TLRY's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as MGTX (100). This means that TLRY’s stock grew similarly to MGTX’s over the last 12 months.

TLRY's SMR Rating (99) in the Biotechnology industry is in the same range as MGTX (100). This means that TLRY’s stock grew similarly to MGTX’s over the last 12 months.

TLRY's Price Growth Rating (34) in the Biotechnology industry is in the same range as MGTX (43). This means that TLRY’s stock grew similarly to MGTX’s over the last 12 months.

TLRY's P/E Growth Rating (94) in the Biotechnology industry is in the same range as MGTX (100). This means that TLRY’s stock grew similarly to MGTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MGTXTLRY
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
80%
Bullish Trend 4 days ago
85%
MACD
ODDS (%)
N/A
Bullish Trend 4 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 4 days ago
81%
Advances
ODDS (%)
Bullish Trend 20 days ago
83%
Bullish Trend 7 days ago
83%
Declines
ODDS (%)
Bearish Trend 6 days ago
83%
Bearish Trend 18 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
87%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CEYRX98.78-0.02
-0.02%
Calvert Equity R6
LHCFX19.81-0.03
-0.15%
Lord Abbett Health Care F
KCSIX13.87-0.06
-0.43%
Knights of Columbus Small Cap I
SIVIX17.63-0.09
-0.51%
State Street Instl Small-Cap Equity Inv
FGFAX44.19-0.28
-0.63%
Federated Hermes International Leaders A

MGTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MGTX has been loosely correlated with IDYA. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if MGTX jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGTX
1D Price
Change %
MGTX100%
-2.54%
IDYA - MGTX
50%
Loosely correlated
-1.52%
KRRO - MGTX
48%
Loosely correlated
-2.49%
AURA - MGTX
47%
Loosely correlated
-2.64%
RGNX - MGTX
46%
Loosely correlated
-0.89%
ZYME - MGTX
46%
Loosely correlated
-0.20%
More

TLRY and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TLRY has been closely correlated with SNDL. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if TLRY jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TLRY
1D Price
Change %
TLRY100%
-6.12%
SNDL - TLRY
76%
Closely correlated
-0.37%
CGC - TLRY
62%
Loosely correlated
-4.26%
CRON - TLRY
61%
Loosely correlated
N/A
OGI - TLRY
60%
Loosely correlated
N/A
ACB - TLRY
56%
Loosely correlated
-3.56%
More